SUMMARY Pyloric muscle dimensions were measured in 1400 consecutive newborn infants. Nine of these subsequently developed pyloric stenosis. Their pyloric measurements at birth were all within the normal range. Congenital preformed muscular hypertrophy does not appear to be present in babies who later develop pyloric stenosis.
Infantile hypertrophic pyloric stenosis is usually classified as a congenital disorder. The condition is almost unknown in stillbirths, however, and usually presents with vomiting starting after the second week of life; this suggests that it may be acquired. Wallgren determine the significance of the change in pyloric dimensions from birth to presentation with infantile hypertrophic pyloric stenosis.
Results
A total of 1400 consecutive newborn infants had pyloric dimensions measured at routine postnatal examination. Nine of these infants subsequently presented to this hospital with infantile hypertrophic pyloric stenosis, which in all cases was confirmed by surgery. The pyloric dimensions recorded are summarised in the table.
The initial pyloric dimensions of the nine infants who presented with infantile hypertrophic pyloric stenosis were no different from the other 1391 healthy newborns. However, there was a highly significant increase (p<0-001) in the size of the Pyloric stenosis: congenital or acquired? 139 pylorus by the time infantile hypertrophic pyloric stenosis was diagnosed.
Discussion
This study shows that pyloric muscle hypertrophy is not present in the early newborn period of infants who later develop infantile hypertrophic pyloric stenosis. It excludes the possibility of a congenital preformed 'soft' hypertrophy of pyloric muscle without constricting effects suggested by Wallgren. The incidence of infantile hypertrophic pyloric stenosis in this study group was 6*4/1000 live births and is in keeping with the previously reported high rising incidence in this area.5 We conclude that infantile hypertrophic pyloric stenosis should no longer be referred to as 'congenital' pyloric stenosis, although the true aetiology of this acquired condition remains to be elucidated.
Plasma aldosterone and renin activity
A M SCAMMELL AND M J DIVER* Institute of Child Health and *Subdepartment of Endocrine Pathology, University of Liverpool SUMMARY Eight infants had paired measurements of plasma aldosterone and plasma renin activity while being treated for congestive heart failure. There is parallelism with aldosterone and renin activity in the presence of a hyperactive reninangiotensin-aldosterone system. Six patients had plasma renin activity and plasma aldosterone measured after commencing captopril and we have shown biochemical blockade of the reninangiotensin-aldosterone system.
We have recently reported raised plasma renin activity in infants being treated for congestive heart failure due to congenital heart disease.1 In that study we were unable to report the results of plasma aldosterone because concentrations fell outside the range of the assay in most instances. We have performed an additional study to determine whether parallelism between plasma renin activity and plasma aldosterone, which has been described in normal infants,2 continues when the renin-angiotensinaldosterone system is hyperactive, and whether this 
